Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Long-Term Deferred Tax (2018 - 2025)

Historic Long-Term Deferred Tax for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $2.8 billion.

  • Takeda Pharmaceutical's Long-Term Deferred Tax rose 1221.62% to $2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 1221.62%. This contributed to the annual value of $2.4 billion for FY2025, which is 1088.29% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Long-Term Deferred Tax of $2.8 billion as of Q4 2025, which was up 1221.62% from $2.6 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Long-Term Deferred Tax high stood at $3.3 billion for Q1 2021, and its period low was $2.1 billion during Q4 2023.
  • Over the past 5 years, Takeda Pharmaceutical's median Long-Term Deferred Tax value was $2.8 billion (recorded in 2023), while the average stood at $2.7 billion.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 2853.51% in 2021, then crashed by 1854.82% in 2023.
  • Over the past 5 years, Takeda Pharmaceutical's Long-Term Deferred Tax (Quarter) stood at $3.1 billion in 2021, then fell by 18.02% to $2.5 billion in 2022, then decreased by 15.78% to $2.1 billion in 2023, then grew by 15.52% to $2.5 billion in 2024, then rose by 12.22% to $2.8 billion in 2025.
  • Its Long-Term Deferred Tax stands at $2.8 billion for Q4 2025, versus $2.6 billion for Q3 2025 and $2.8 billion for Q2 2025.